Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 655 institutions that hold shares in the stock, with a total of 95.9 Million shares, which have been reported (via 13F filing form) to have a value of $9.1 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,190,708
shares
|
$1.35 Billion
0.04% of portfolio
|
Q2 2024
Added 3.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
10,119,641
shares
|
$960 Million
0.02% of portfolio
|
Q4 2024
Added 1.23%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,891,137
shares
|
$464 Million
0.03% of portfolio
|
Q4 2024
Reduced 4.99%
|
|
|
Dodge & Cox
San Francisco, CA |
Feb 13, 2025 Q4 2024 |
3,016,425
shares
|
$286 Million
0.26% of portfolio
|
Q4 2024
Added 134.23%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,538,109
shares
|
$241 Million
0.06% of portfolio
|
Q4 2024
Added 43.84%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,489,397
shares
|
$236 Million
0.54% of portfolio
|
Q4 2024
Reduced 3.31%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,896,891
shares
|
$180 Million
0.34% of portfolio
|
Q4 2024
Added 2.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,875,062
shares
|
$178 Million
0.02% of portfolio
|
Q4 2024
Added 0.85%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
1,820,000
shares
|
$173 Million
4.95% of portfolio
|
Q4 2024
Reduced 2.35%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,573,297
shares
|
$149 Million
0.02% of portfolio
|
Q4 2024
Added 16.59%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,490,513
shares
|
$141 Million
0.02% of portfolio
|
Q4 2024
Reduced 11.02%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,371,186
shares
|
$130 Million
0.02% of portfolio
|
Q4 2024
Reduced 8.46%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
1,347,820
shares
|
$128 Million
0.21% of portfolio
|
Q3 2022
Reduced 8.29%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,070,096
shares
|
$102 Million
0.03% of portfolio
|
Q4 2024
Added 19.67%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
983,799
shares
|
$93.4 Million
0.02% of portfolio
|
Q4 2024
Reduced 3.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
981,939
shares
|
$93.2 Million
0.02% of portfolio
|
Q4 2024
Added 27.26%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
949,512
shares
|
$90.1 Million
0.03% of portfolio
|
Q4 2024
Added 8.56%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Feb 11, 2025 Q4 2024 |
944,738
shares
|
$89.6 Million
0.32% of portfolio
|
Q4 2024
Added 15.22%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
938,120
shares
|
$89 Million
3.47% of portfolio
|
Q4 2024
Added 210.41%
|
|
|
Dsm Capital Partners LLC
Palm Beach Gardens, FL |
Jan 31, 2025 Q4 2024 |
932,595
shares
|
$88.5 Million
2.21% of portfolio
|
Q4 2024
Reduced 1.22%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
924,416
shares
|
$87.7 Million
0.1% of portfolio
|
Q2 2023
Added 27.64%
|
|
|
Braidwell LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
901,790
shares
|
$85.6 Million
6.9% of portfolio
|
Q4 2024
Reduced 1.73%
|
|
|
Brown Advisory Inc
|
Feb 14, 2025 Q4 2024 |
898,293
shares
|
$85.2 Million
0.16% of portfolio
|
Q4 2024
Reduced 4.65%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
892,000
shares
|
$84.6 Million
1.72% of portfolio
|
Q4 2024
Added 391.78%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
862,000
shares
|
$81.8 Million
2.91% of portfolio
|
Q4 2024
Reduced 34.53%
|